Kevin Jerome Madden

Kevin J. Madden is of counsel in the firm’s Boston office.

Mr. Madden advises private equity sponsors and public and private company clients on a broad range of transactions, including mergers and acquisitions, leveraged buyouts, growth and venture investments, and divestitures.

He represents clients operating in a range of industries including technology, life sciences, health care, food, and manufacturing.

Prior to joining Morrison & Foerster, Mr. Madden practiced in the Boston office of another international law firm, where he advised private equity sponsors and public and private companies on corporate and transactional matters.

• Represented a Boston-based private equity firm and its portfolio companies in buy-side (including leveraged buy-outs) and sell-side mergers, stock and asset sales transactions, including cross-border transactions, valued between $15 million to $950 million.
• Advised a Boston-based private equity firm in connection with the disposition of a California-based royalty business.
• Advised a New York-based private equity firm in connection with two acquisitions in the food manufacturing and services business.
• Advised a national homecare nursing company in connection with its sale.
• Represented searchers in the formation of search funds and fundraising, acquisitions, and ongoing corporate matters.
• Represented a data analytics company in its sale to a clinical trial SaaS company.
• Advised an online backup services company in a strategic transaction.
• Represented an internet and healthcare company in its sale to a global health services company.
• Represented a long-term care pharmacy in its sale to a strategic acquirer.
• Represented a dermatology practice in its sale to a portfolio company of a U.S.-based private equity fund.
• Advised a privately held manufacturing and tool company in connection with several strategic transactions and operations.
• Represented a major cloud computing company in the acquisition of companies in various countries, valued between $5 million and $500 million.
• Worked as part of a team representing a test instrument manufacturer in a public merger valued at $291 million.
• Advised a national bank in the sale of its wholly-owned insurance subsidiary in an auction process.
• Represented venture-backed technology companies in a variety of preferred equity financings.
• Advised a large institutional investor in more than 10 late stage/pre-IPO preferred equity financings.
• Represented private equity sponsors and portfolio companies in minority and growth equity investments.